The invasion of activated fibroblasts represents a key pathomechanism in fibrotic diseases, carcinogenesis and metastasis. Invading fibroblasts contribute to fibrotic extracellular matrix (ECM) formation and the initiation, progression, or resistance of cancer. To construct transcriptome-wide signatures of fibroblast invasion, we used a multiplex phenotypic 3D invasion assay using lung fibroblasts. Microarray-based gene expression profiles of invading and non-invading fibroblasts demonstrated that 1,049 genes were differentially regulated (>1.5-fold). Unbiased pathway analysis (Ingenuity) identified significant enrichment for the functional clusters 'invasion of cells', 'idiopathic pulmonary fibrosis', and 'metastasis'. Matrix metalloprotease 13 (MMP13), transforming growth factor (TGF)-β1, Caveolin (Cav) 1, Phosphatase and Tensin Homolog (Pten), and secreted frizzledrelated protein (Sfrp) 1 were among the highest regulated genes, confirmed by qRT-PCR and Western Blotting. We next performed in silico analysis (Ingenuity Pathway Analysis) to predict mediators that induced fibroblast invasion. Of these, TGFβ1, epidermal growth factor (EGF), fibroblast growth factor (FGF) 2, and platelet-derived growth factor (PDGF)-BB were tested in our 3D invasion assay and found to significantly induce invasion, thus validating the transcriptome profile. Accordingly, our transcriptomic invasion signature describes the invading fibroblast phenotype in unprecedented detail and provides a tool for future functional studies of cell invasion and therapeutic modulation thereof using complex phenotypic assays.
wounding 4 . Importantly, the mode of interstitial migration differs between various cell types: leukocytes are mainly found to display an integrin-independent amoeboid mode of migration, while most cancer cells and fibroblasts display mesenchymal movements 5 . In tissue fibrosis, such as idiopathic pulmonary fibrosis (IPF), areas of activated fibroblasts, are believed to represent the site of increased production, secretion, and deposition of ECM 6, 7 . In the lung, α -smooth muscle actin (α SMA)-positive fibroblasts originate from the sub-pleural region and form a fibroblastic reticular structure into the interstitium 8 . It is widely assumed that this process requires an invading fibroblast phenotype 9 . During injury, repair, and fibrosis, a plethora of soluble mediators are released by different cell types, which activate and attract resident fibroblasts and/or induce transformation of epithelial or pleural mesothelial cells (PMC) into mesenchymal-like cells [10] [11] [12] [13] . Such aberrantly activated mesenchymal cells exhibit an exceptional plasticity with respect to proliferation, apoptosis, ECM deposition, activation, and tissue invasion 11 . In agreement with this concept, an increased collagen-invading capacity of human lung fibroblasts derived from IPF patients has recently been reported in 2D assays 14 . Furthermore, keloid fibroblasts are suggested to exhibit a highly invasive character, inducing infiltration of these fibroblasts into surrounding healthy skin tissue 15 . Enhanced fibroblast invasion, however, does play a decisive role in carcinogenesis and metastasis, as the tumour microenvironment is increasingly recognized as a major feature of tumour progression 3 . Here, the crosstalk between cancer cells and cells of the neoplastic stroma are important factors for invasive tumour growth and metastasis 16, 17 . In particular, cancer associated fibroblasts (CAF) have been reported to represent key determinants in cancer progression 2 . Studies using squamous cell carcinoma (SCC) cells and stromal fibroblasts revealed that force-and protease-mediated matrix remodelling by the fibroblast is required for collective invasion of the SCC cells 18 , indicating that invading fibroblasts are able to direct carcinoma cells through stromal tissue.
In the current study, we hypothesized that pathway analysis of the transcriptome-wide signature of invading lung fibroblasts by comparative microarray analyses, using a collagen-based invasion assay previously established in our lab 19 , will identify pro-invasive growth factors with relevance to disease. To this end, we generated a specific fibroblast invasion signature, followed by functional validation of in silico-predicted upstream regulators of fibroblast invasion; namely transforming growth factor (TGF)β 1, epidermal growth factor (EGF), fibroblast growth factor 2 (FGF2), and platelet-derived growth factor (PDGF)-BB. Prospectively, this validated fibroblast invasion signature will enable the identification of yet unknown invasion-relevant molecular networks and underlying mechanisms thereof. Thus, this invasion signature advances the understanding of an activated invasive fibroblast phenotype in particular for fibrotic and metastatic pathologies.
Results Section
Deciphering a transcriptomic signature for invading fibroblasts. In order to systematically identify the molecular signature of invading fibroblasts we applied a whole transcriptome analysis (Affymetrix Mouse Gene 1.0 ST array), using our recently established 3D invasion assay 19 . A subpopulation of murine MLg 2908 (MLg) lung fibroblasts spontaneously invaded a 3D collagen matrix when plated on top of it 19 . Separation of invading from non-invading MLg fibroblasts was carried out 72 or 96 hours after plating. RNA isolation and subsequent whole transcriptome analysis provided gene expression profiles of invading and non-invading fibroblasts. Transcripts with a false discovery rate < 10% were considered as being statistically significant regulated and were used for subsequent analyses. After 72 hours of invasion, 1,086 targets with expression ratios greater than 1.5-fold and 163 targets regulated greater than 2-fold were identified in the invading fraction as compared to the non-invading fraction. In fibroblasts that invaded the matrix for 96 hours, an altered regulation of 1,049 probes with expression ratios greater than 1.5-fold and 182 greater than 2-fold were identified (Fig. 1A ). Hierarchical clustering of the different fractions is depicted in Fig. 1B . Heatmaps of up-and down-regulated target genes (> 2-fold) in the invading fractions at 72 hours and 96 hours validate the reproducibility of our replicate analyses ( Fig. 2A and Fig. 2B ). The whole array data have been submitted to GEO (GSE55322).
Predictive in silico cluster analysis and validation of the gene expression profile of fibroblast invasion. The gene expression profiles of the invading fibroblasts at 72 hours and 96 hours (> 1.5-fold) greatly overlapped: among the differentially regulated genes in the invading subtype at 72 and 96 hours, 621 genes overlapped in total: 166 in the up-and 455 in the down-regulated group (Fig. 3A) . Of note, there were more than twice as many overlapping down-regulated genes than overlapping up-regulated genes. This comparative approach allowed us to enrich for those targets that are commonly regulated after 72 and 96 hours of invasion and to define the invasion signature of fibroblasts. Enrichment analyses using IPA's 'disease and function' ontology revealed that 'invasion of cells' , 'idiopathic pulmonary fibrosis (IPF)' , and 'metastasis' ranked as the top three most significantly over-represented 'disease processes' and 'biological functions' within the invasion signature (Fig. 3B ). In agreement with the well-known role of TGFβ 1 in invasion and fibrosis, TGFβ 1 associated with all three key networks of invasion (Fig. 3C ). These data clearly corroborate our experimental approach. In order to further validate the profiling approach used, several known invasion-promoting genes were chosen for confirmative expression analysis by qRT-PCR. These targets included matrix metalloprotease 13 (MMP13) 20, 21 , TGFβ 1 10, 22 , Caveolin 1 (Cav1) 23 , secreted frizzled-related protein (Sfrp) 1 24 , and Phosphatase and Tensin Homolog (Pten) 25, 26 Scientific RepoRts | 5:12673 | DOi: 10.1038/srep12673
( Fig. 4A,B) . Consistent with our microarray data ( Fig. 4C) , qRT-PCR analysis demonstrated a significant up-regulation of MMP13 and TGFβ 1 in the invading fibroblasts by 6-and 1.8-fold, respectively (Fig. 4D ). By contrast, Cav1, Sfrp1, and Pten were significantly down-regulated by 3.5-, 2.9-, and 2.6-fold, respectively (Fig. 3D) . Reduced Sfrp1 and Cav1 protein expression was further corroborated by immunoblot analysis (Fig. 4E) . Furthermore, TGFβ 1 and MMP13 19 were up-regulated on protein level as well (Fig. 4E) . Interestingly, the protein expression of Pten, which was strongly diminished on transcript level, was found to be largely unchanged. Additionally, in primary human lung fibroblasts we identified a corresponding regulation of the same target genes in the invading subpopulation (Fig. 4F) . The qRT-PCR analyses of selected target genes thus validated the robustness of our invasion assay and the identified gene signature for invading fibroblasts.
Identification and validation of upstream regulators for fibroblast invasion. In order to further validate the generated transcriptomic fibroblast invasion signature, gene expression lists were evaluated with the causal analysis tool 'upstream regulator analysis' (URA), implemented in IPA. This approach allowed the identification of putative upstream regulators for subsequent functional testing in regards to fibroblast invasion. In order to measure the enrichment of potentially activated upstream regulators we used a ranking based on the p-value 27 obtained from the overlap between our experimentally derived gene datasets and those from the IPA's database. As physiological upstream regulators were of particular interest, we excluded 'drugs' , and 'chemicals' from the URA. The 'p-value of overlap' in supplementary Table 1 depicts a ranking of physiological upstream regulators according to their p-values for the comparison of gene expression data at 72 and 96 hours upon invasion. The cut-off value for the ranking (negative logarithmic p-value) was set to 4. By using a more stringent filter for 'growth factors' , we were able to extract four growth factors, which all were found to be associated with fibrotic and/or cancerous diseases in the literature (Fig. 5A) . Notably, TGFβ 1, which is a prominent and potent activator of fibroblasts, ranked high among the predicted upstream regulators (p-value 96 hours = 3.2 × 10 −10
, p-value 72 hours = 1.4 × 10
−6
). In line with its key role in fibrogenesis, in the microarrays we found the expression of TGFβ 1 to be significantly increased in the invading fibroblast fraction and moreover, also predicted to be associated with the generated functional gene clusters 'IPF' , 'invasion of cells' , and 'metastasis' in the in silico gene cluster analysis (Fig. 3C ). Further putative upstream regulators from the URA, which were chosen for functional analysis in the following due to their association to fibrotic and cancerous diseases, comprised epidermal growth factor (EGF), basic fibroblast growth factor (FGF) 2, and platelet derived growth factor (PDGF)-BB. EGF, was predictively activated in the invading fibroblast fraction with a p-value 96 hours = 10.0 × 10 −6 and a p-value 72 hours = 4.8 × 10 −5 ( Fig. 5A ), while its receptor EGFR was also predicted to be activated (p-value 96 hours = 6.3 × 10 −9 and a p-value 72 hours = 4.0 × 10
) (supplementary Table 1 ). In our transcriptomic invasion signature, FGF2 was another highly ranked candidate in the predicted list of upstream regulators (p-value 96 hours = 7.0 × 10 −8 and p-value 72 hours = 2.8 × 10
), which was associated with fibrotic or cancerous diseases. Furthermore, PDGF-BB was predicted to be activated based Figure 1 . Analysis of differentially regulated targets of invading vs non-invading fibroblasts and hierarchical clustering. After 72 hours of invasion, 1,086 targets with expression ratios greater than 1.5-fold and 163 targets regulated greater than 2-fold were identified in the invading fraction. After 96 hours, an altered regulation of 1,049 probes with expression ratios greater than 1.5-fold and 182 greater than 2-fold were identified. The FDR for all of these targets was lower than 10%. The proportion of genes with expression ratios of 1 < > 1.5 between invading (inv.) and non-invading (non-inv.) phenotypes are depicted in light grey. The amount of targets with an expression ratio of >1.5 and > 2 is represented in dark grey and black, respectively (a). Hierarchical clustering distinguished two main clusters: invading (inv.) and noninvading (non-inv.) and two sub-clusters: 72 and 96 hours. The cluster dendrogram was conducted with R using the script hclust, on RMA data filtered for expression values >100 in at least one sample (b).
on the invasion signature with p-value 96 hours = 3.8 × 10 −6 and a p-value 72 hours = 2.3 × 10
. Grounded on these computational predictions of activated upstream regulators, we next performed functional confirmative studies in vitro. Therefore, the invasive capacity of MLg fibroblasts was assessed by using the automated software-based invasion assay recently established in our lab 19 . The fibroblasts were treated with the particular growth factor and the invasion capacity was measured after 72 hours total invasion time as previously described 19 . TGFβ 1 (1 and 5 ng/ml) significantly enhanced the fibroblast invasion capacity to 138.2 ± 28.7% (p-value ≤ 0.01) and 141.7 ± 38.1% (p-value ≤ 0.01), compared to untreated controls (Fig. 5B) . EGF (10 and 50 ng/ml) significantly increased the cellular invasion to 178 ± 57.0% and 193.3 ± 64.2% (p-value ≤ 0.05), respectively (Fig. 5C ). FGF2 exhibited the strongest significant effect on the invasion capacity with a mean relative induction of 246.8 ± 58.9% (10 ng/ml) (p-value ≤ 0.05) and 235.0 ± 64.2% (50 ng/ml) (p-value ≤ 0.05) (Fig. 5D) . PDGF-BB (5 and 25 ng/ml) initiated a significant effect of 114.4 ± 17.6% (p-value ≤ 0.05) and 134.9 ± 23.0% (p-value ≤ 0.001) relative invasion (Fig. 5D ). Supplementary Fig. S1 depicts representative images of either untreated or TGFβ 1-, and FGF2-treated fibroblasts invading the collagen gel. Next, we used immunoblot analyses to demonstrate expression of the receptors for the above identified growth factors in lung fibroblasts. Protein expression of TGFβ RI and II, EGFR, FGFR1 and 2, as well as PDGFRα and β was assessed in fibroblasts cultured on the 3D collagen matrix at the time of cell treatment. In addition, the expression levels of these receptors upon invasion were extracted from the microarray data for 72 and 96 hours of invasion (Fig. 6 ). While mRNA expression levels of TGFβ RII and EGFR were detected but significantly reduced in invading cells at both time-points, FGFR1 and FGFR2 mRNA levels were increased. PDGFRα and β were expressed, but unchanged during invasion. Taken together, we have generated and identified, using a novel high content 3D invasion assay, a specific transcriptome signature of fibroblast invasion that shows a strong relation to invasive diseases, such as fibrosis and cancer.
Discussion
The dynamic processes of tissue remodelling and repair that take place as a physiological response to tissue injury depend on an active and versatile fibroblast phenotype that ultimately restores normal tissue architecture and homeostasis 28 . Conversely, aberrantly activated fibroblasts are known to be involved in the initiation and progression of most malignant diseases such as cancer and fibrosis 6, 16, 29 . One substantial feature of activated fibroblasts is their increased invasive capacity 2, 14 . The herein identified invasion signature included several genes that were previously reported to play essential roles for cellular invasion. In the expression profile of the invading fibroblast, the interstitial collagenase MMP13 and TGFβ 1 were found to be significantly up-regulated while Cav1, Pten, and Sfrp1 were down-regulated on mRNA level. Finding MMP13 as one of the most highly up-regulated transcript in the invasion signature indicates that ECM degradation likely assists in the process of fibroblast invasion in the 3D invasion model. In a pathophysiological context, MMP13 expression in invading fibroblasts was found to not only drive their own invasion, but also influences the invasive capacity of carcinoma cells as indicated by MMP13 expression in subsets of activated carcinoma-associated fibroblasts (CAFs) 20, 30 . Up-regulation of MMP13 together with MMP1 and MMP7 31 in lung homogenates occurs in IPF, with the main cellular source of MMP13 being the lung epithelium and interstitial spaces 32 . Additionally, Cav1 and Pten, which were widely studied in the context of fibrosis and cancer, as well as cellular invasion, were included in our list of differentially expressed targets upon invasion 25, 26, [33] [34] [35] . Activated fibroblasts in IPF were reported to exhibit decreased Pten expression, correlating with increased α SMA levels 36 . Furthermore, α 5β 1 integrin-mediated invasion of lung fibroblasts was found to be circumvented through the reactivation of Pten activity by α 4β 1 integrin 25 . Pten also acts as stabilizer of junctional complexes in epithelial kidney cells, thereby preventing transformation to an invasive phenotype 26 . Furthermore, Pten was reported to suppress 2D cell migration and invasion in Boyden chamber in vitro assays in fibroblasts 37, 38 . Interestingly, using our 3D invasion assay, protein expression of Pten did not correlate with the down-regulation of Pten on transcript level upon invasion, but remained unchanged when comparing invading with non-invading fibroblasts. This could advocate a more complex regulation of protein expression of Pten on various levels, including translation, protein stability and its turnover, or epigenetic mechanisms, all of which might be altered upon cellular invasion. Actually, the expression of Pten was reported to be regulated by miR-18a in a stiffness-dependent manner 39 , which could influence and alter its expression levels when using soft 3D matrices, such as collagen I. In IPF, down-regulation of Pten in fibroblastic foci was found to be accompanied by decreased Caveolin 1 (Cav1) levels. Diminished Cav1 thereby reduce membrane-associated Pten, which in turn favours the activation of PI3K/Akt signal pathway 40 . Furthermore, Sfrp1 was found to be down-regulated upon fibroblast invasion. Sfrps are a family of glycoproteins that can trigger Wnt signalling cascades by binding to Wnt ligands and Frizzled receptors 41 . Transcriptional silencing of Sfrp1 was previously reported in non-small cell lung cancer 42 and in fibroblasts derived from keloid lesions 43 , Systemic Sclerosis (SSc) 44 , and IPF fibrotic lungs 45 . In breast cancer, ectopic expression of Sfrp1 in highly invasive human derived MDA-MB-231 adenocarcinoma cells decreased the migratory potential of the cells and impaired tumour outgrowth, and blocked lung metastases 24 . Reduction of Sfrp1 expression by TGFβ 1 treatment with a concomitant increase in cell invasion and migration was reported in A549 human lung adenocarcinoma cell line 46 . We also identified TGFβ 1, one of the best characterized profibrotic mediators, to be up-regulated in the invasion signature 47 . Here, TGFβ 1 was found to be predictively associated with the functional clusters 'invasion of cell' , 'idiopathic pulmonary fibrosis (IPF)' , and 'metastasis' . As the mere expression level of upstream regulators such as TGFβ 1 was found to be significantly higher in invading fibroblasts, we aimed to validate the functional relevance of the generated invasion signature by using a systematic approach (Upstream Regulator Analysis (URA), Ingenuity). URA has frequently been used in the literature [48] [49] [50] . URA enables to elucidate upstream biological causes to gene-expression datasets and thus allows interpretation of gene expression data beyond gene cluster enrichment 27 . Using such causal networks in order to identify biological cause-effect relationships based on gene expression data is more powerful and relevant than looking at changes in gene expression levels alone 27 . The URA of differentially expressed genes comparing invading to non-invading fibroblasts provided us with an activation list of upstream regulators of various molecule types such as cytokines, chemical drugs, kinases, transcriptional regulators, growth factors, and others. The activation of the upstream regulators is entirely based on prediction grounded on the Ingenuity Knowledge Base, which is a large collection assembled from already published findings or third-party databases. Therefore, from the list of predictively activated upstream regulators, we functionally tested several cancer-and/or fibrosis-associated growth factors in our 3D invasion assay. Consistent with the URA prediction of our experimentally derived invasion signature, TGFβ 1 induced fibroblast invasion. Taking into consideration that activated, invading fibroblasts in the 3D invasion model express higher levels of TGFβ 1, this invading fibroblast phenotype may initiate the activation of adjuvant fibroblasts in a pathophysiological context. Besides TGFβ 1, the identification and functional verification of additional cancer or fibrosis-associated factors, EGF, FGF2 and PDGF-BB, further confirmed the functional relevance of the invasion signature. In fibrotic and cancerous diseases, epidermal growth factor (EGF) represents one potent inducer of cellular invasion, which was also shown for breast and prostate cancer cells, oral carcinoma cells 51 , and human dermal fibroblasts 52 . Moreover, FGF2 was reported to be highly expressed in osteosarcoma-associated stromal cells 53 , and the expression of FGF2 was shown to be enhanced in renal fibrosis 54 as well as in bronchoalveolar lavage fluid of IPF patients 55 . Furthermore, the inhibition of fibroblast growth factor receptor (FGFR) 1, the predominant receptor for FGF2, ameliorated hepatic fibrosis in a rodent model 56 . Another highly ranked candidate predicted to be an activated upstream regulator in our transcriptomic invasion signature was PDGF-BB. Most recently, PDGF-BB/PDGFR-β signalling was reported to contribute to fibrocyte migration in pulmonary fibrosis 57 . In addition, an involvement of this signalling cascade was suggested for cervical cancer 58 . Furthermore, it was suggested that cancer cells, secreting high amounts of PDGF activate adjuvant fibroblasts through a paracrine mechanism 59 . As of now the exact mechanisms that regulate fibroblast activation and their role in the initiation and progression of diseases such as fibrosis and cancer are not fully understood. Anyway, fibroblasts might be a potent target for therapeutic intervention. As such, the transcriptomic invasion signature of fibroblasts presented in our study describes the invading phenotype to unprecedented detail and provides a powerful repository for future studies on fibroblast invasiveness and the feasibility of defining therapeutic strategies in targeting activated fibroblasts. In particular, secreted proteins such as MMP13 or Sfrp1, may represent promising therapeutic targets in pathologies exhibiting fibroblast invasion. By systematically analysing the interactome of the components identified herein, we will be able to further refine the mechanistic processes involved in fibroblast activation and invasion.
Material and Methods
Antibodies. For immunoblotting the following primary (1) and secondary antibodies (2) were used: Cell Culture. Mouse lung fibroblasts, MLg (MLg 2908) were purchased from ATCC (Manassas, VA, USA) (CCL-206) and cultivated in DMEM/HAM's F12 (catalog# E15-813, PAA (Pasching, Austria)) medium containing 10% FBS (PAA). For isolation of primary human lung fibroblasts, specimens from lung lobes or segmental lung resections were dissected into pieces of 1-2 mm 2 in size and digested by 5 mg of Collagenase I (Biochrom (Berlin, Germany)) at 37 °C for 2 hours. Subsequently, samples were filtered through nylon filters with a pore size of 70 μ m (BD Falcon, (Bedford, MA, USA)). Filtrates, containing the cells, were centrifuged at 400 g, 4 °C for 5 minutes. Pellets were resuspended in DMEM/F-12 medium (Gibco, (Darmstadt, Germany)) supplemented with 20% fetal bovine serum (PAA) and plated on 10 cm cell-culture dishes and subsequently cultured to a confluence of 80-90% in DMEM/HAM's F12 medium containing 20% FBS. All cells were cultivated under standard conditions (5% CO 2 and 37 °C). MLg fibroblasts and primary cells were not used at passage numbers higher than 15 and 10, respectively. 3D Collagen Invasion Assay. 3D cell culture assays were performed as previously described 19 . 2 × 10 4 cells per well were seeded on top of the matrix and left for invasion under standard conditions (37 °C, 5% CO 2 ) in DMEM/HAM's F12 medium containing 5% FBS. Treatment of cells with recombinant epidermal growth factor (EGF) (Sigma), transforming growth factor beta-1 (TGFβ 1) (R&D, Minneapolis, MN, USA)), fibroblast growth factor (FGF) 2 (R&D) or platelet derived growth factor (PDGF) BB (life technologies; Carlsbad, USA) was accomplished by treating cells with 10-50 ng/ml EGF and FGF2, 1-5 ng/ ml TGFβ 1, or 5-25 ng/ml PDGF-BB 24 hours after plating, and culturing them up to 72 hours in total.
Separation Assay, Protein and mRNA Isolation from collagen-embedded Cells. The separation of invading from non-invading cells and the isolation of protein and mRNA was performed as previously described 19 . For immunoblot analysis of growth factor receptors, 5 × 10 5 cells were plated on top of 1.5 ml polymerized collagen G (Biochrom) per well of a 6-well plate in DMEM/HAM's F12 medium containing 5% FBS. Protein isolation was performed 24 hours after plating, as described before 19 .
mRNA Isolation and qRT-PCR. mRNA from fibroblasts, cultured in the 3D cell culture model, was isolated as previously described cDNA was synthesized with the GeneAMP PCR kit (Applied Biosystems (Foster City, CA, USA)) utilizing random hexamers using 1 μ g of isolated RNA for one reaction. Microarray. For microarray analysis, total RNA was isolated with the miRNeasy mini kit ® according to the manufacturer's protocol (Qiagen (Hilden, Germany) ). RNA quality was accessed by the Agilent 2100 Bioanalyzer and only high quality RNA (RIN > 8) was used for microarray analysis. Total RNA (150 ng) was amplified using the Ambion WT Expression Kit and the WT Terminal Labeling Kit (Affymetrix (Santa Clara, USA)). Amplified cDNA (2.75 μ g) was hybridized on Affymetrix Mouse Gene 1.0 ST arrays containing about 28,000 probe sets. Staining (Fluidics script FS450_0007) and scanning was done according to the Affymetrix expression protocol. For the statistical transcriptome analysis, expression console (Affymetrix) was used for quality control and to obtain annotated normalized RMA gene-level data (standard settings including sketch-quantile normalisation). Array data has been submitted to GEO (GSE55322).
Protein Isolation, SDS-PAGE and Western Blotting. Protein from fibroblasts, cultured in the 3D cell culture model, was isolated as previously described 19 . Samples were mixed with 50 mM Tris-HCl, pH 6.8, 100 mM DTT, 2% SDS, 1% bromphenol blue, and 10% glycerol, and proteins were separated using standard SDS-10% PAGE. For immunoblotting, proteins were transferred to PVDF (Millipore (Billerica, MA, (USA)), 0.45 μ m or 0.2 μ m) membranes, which were blocked with 5% milk in TBST (0.1% Tween 20/TBS) and incubated with primary, followed by HRP-conjugated secondary antibodies over night at 4 °C and at room temperature for 1 hour, respectively.
In silico analysis. Regulated gene sets from the microarray data were analyzed through the use of IPA (Ingenuity ® Systems, www.ingenuity.com). The 'disease and function' ontology was used to determine significantly enriched terms (p > 0.01, Right-tailed Fisher's exact test). Upstream regulator activation analysis (URA) implemented in IPA was used to predict activators that are directly or indirectly connected to the dataset of genes. Upstream regulators with a p-value of overlap ≤ 0.0001 and a positive activation z-score at both timepoints were considered activated.
Statistics. Statistical analysis was performed using GraphPad Prism4 (GraphPad Software). Data are presented as mean ± s.d. Statistical analysis was performed using unpaired and paired t-tests (two-tailed) or One way ANOVA with Dunnett's multiple comparison test. For microarray experiments statistical analyses were performed by utilizing the statistical programming environment R implemented in CARMAweb 60 . Genewise testing for differential expression was done employing limma t-test and Benjamini-Hochberg multiple testing correction (FDR < 10%). Right-tailed Fisher Exact Test was utilized for statistical analysis on the Ingenuity Pathways Analysis (IPA) platform (Ingenuity Systems (Redwood City, CA, USA)).
